Ravidasvir is a chemical compound investigated for its role as an active pharmaceutical ingredient, primarily in research related to antiviral activity against the HCV NS5A protein. Its structure features a large, flexible molecule with multiple ring systems and polar groups, as indicated by its physical descriptors.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ravidasvir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Daclatasvir
pharmaceutical raw material
Daclatasvir dihydrochloride
pharmaceutical raw material
Fingolimod Palmitate Amide
pharmaceutical raw material
Nesiritide
pharmaceutical raw material
N-Boc Alogliptin
pharmaceutical raw material
3-[3-({[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}amino)propyl]-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one--hydrogen chloride (1/1)
pharmaceutical raw material
The international HS code for Ravidasvir (CAS 1242087-93-9) is 2933.29.
2933.29
2933 29 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
methyl N-[(2S)-1-[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]naphthalen-2-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
LCHMHYPWGWYXEL-ZYADHFCISA-N
CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)[C@@H]7CCCN7C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
Sourcing Ravidasvir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.